Shandong Institute of Medical Instruments

Jinan, China

Shandong Institute of Medical Instruments

Jinan, China
SEARCH FILTERS
Time filter
Source Type

News Article | February 17, 2017
Site: marketersmedia.com

The research report on the global Insulin Delivery market studies the market in the past based on which estimates are presented for the future. The report looks into vital market indicators, trends, and opportunities that will have a bearing on the development of this market. The report begins with an outline of terms and terminologies, classifications, and applications that are standard conventions in the global Insulin Delivery market. A glance into the industry chain structure and industry statutes that govern this industry are presented herein. Following this, operational parameters of the Insulin Delivery market such as manufacturing processes, product catalog, and cost structures are discussed at length in this report. This, in turn, helps to understand production capacity, product pricing and profit, and demand and supply gap for new entities interested in participating in the global Insulin Delivery market. This analysis is also indicative how operational aspects of the global Insulin Delivery market will impact the development of the market until the end of the forecast period. The report discusses the competitive landscape of the global Insulin Delivery market at length. The major companies that have a significant presence in this market are profiled for business attributes such as financial standing, production capacity, and SWOTs. Each of these companies is studied with reference to a timescale, in order to comprehend the changing competitive hierarchy of the global Insulin Delivery market over the past few years. The report is compiled in a chapter-wise format for reading comprehensibility, with each chapter discussing the progression analysis of a specific aspect of the market at length. 1 Industry Overview 1.1 Definition and Specifications of Intragastric Balloons 1.2 Classification of Intragastric Balloons 1.3 Applications of Intragastric Balloons 1.4 Industry Chain Structure of Intragastric Balloons 1.5 Industry Regional Overview of Intragastric Balloons 1.6 Industry Policy Analysis of Intragastric Balloons 1.7 Industry News Analysis of Intragastric Balloons 2 Manufacturing Cost Structure Analysis of Intragastric Balloons 2.1 Raw Material Suppliers and Price Analysis of Intragastric Balloons 2.2 Equipment Suppliers and Price Analysis of Intragastric Balloons 2.3 Labor Cost Analysis of Intragastric Balloons 2.4 Other Costs Analysis of Intragastric Balloons 2.5 Manufacturing Cost Structure Analysis of Intragastric Balloons 2.6 Manufacturing Process Analysis of Intragastric Balloons 7 Analysis of Intragastric Balloons Industry Key Manufacturers 7.1 Helioscopie Medical Implants 7.1.1 Company Profile 7.1.2 Product Picture and Specifications 7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.1.4 Contact Information 7.2 Allurion? 7.2.1 Company Profile 7.2.2 Product Picture and Specifications 7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.2.4 Contact Information 7.3 Apollo Endosurgery 7.3.1 Company Profile 7.3.2 Product Picture and Specifications 7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.3.4 Contact Information 7.4 Spatz FGIA? 7.4.1 Company Profile 7.4.2 Product Picture and Specifications 7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.4.4 Contact Information 7.5 Tulip Medical Products 7.5.1 Company Profile 7.5.2 Product Picture and Specifications 7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.5.4 Contact Information 7.6 Sterlab 7.6.1 Company Profile 7.6.2 Product Picture and Specifications 7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.6.4 Contact Information 7.7 Shandong Institute of Medical Instruments 7.7.1 Company Profile 7.7.2 Product Picture and Specifications 7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.7.4 Contact Information 7.8 Silimed 7.8.1 Company Profile 7.8.2 Product Picture and Specifications 7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.8.4 Contact Information 7.9 ReShape Medical 7.9.1 Company Profile 7.9.2 Product Picture and Specifications 7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.9.4 Contact Information 7.10 PlenSat? 7.10.1 Company Profile 7.10.2 Product Picture and Specifications 7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.10.4 Contact Information 7.11 Phagia Technologies 7.11.1 Company Profile 7.11.2 Product Picture and Specifications 7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.11.4 Contact Information 7.12 Obalon Therapeutics 7.12.1 Company Profile 7.12.2 Product Picture and Specifications 7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.12.4 Contact Information 7.13 Medsil 7.13.1 Company Profile 7.13.2 Product Picture and Specifications 7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.13.4 Contact Information 7.14 Medicone 7.14.1 Company Profile 7.14.2 Product Picture and Specifications 7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.14.4 Contact Information 7.15 Life Partners Europe 7.15.1 Company Profile 7.15.2 Product Picture and Specifications 7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.15.4 Contact Information 7.16 Lexal Srl 7.16.1 Company Profile 7.16.2 Product Picture and Specifications 7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.16.4 Contact Information 7.17 Fengh Medical 7.17.1 Company Profile 7.17.2 Product Picture and Specifications 7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.17.4 Contact Information 7.18 Endalis 7.18.1 Company Profile 7.18.2 Product Picture and Specifications 7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.18.4 Contact Information 7.19 Districlass Medical 7.19.1 Company Profile 7.19.2 Product Picture and Specifications 7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.19.4 Contact Information 7.20 BaroNova Therapeutics 7.20.1 Company Profile 7.20.2 Product Picture and Specifications 7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue 7.20.4 Contact Information For more information, please visit https://www.wiseguyreports.com/sample-request/98638-global-insulin-delivery-industry-report-2015


Wang Q.,Shandong Institute of Medical Instruments | Liu J.-Y.,Shandong Provincial Hospital | Wang C.-D.,Shandong Institute of Medical Instruments | Ma L.-X.,Shandong Institute of Medical Instruments | And 3 more authors.
IFMBE Proceedings | Year: 2013

PLLA and PGLA sutures for decomposable esophageal stent were investigated in phosphate buffer solution (PBS) (pH=7.4) at 37°C for period of 8 weeks. The in vitro degradation was studied by determining the change of weight loss, pH value, intrinsic viscosity, tensile strength, orientation degree, degree of crystallinity, melting point and surface morphology of the suture samples. The results showed that all properties of PLLA sutures had no obvious changes, however, the properties of PGLA sutures all changed significantly. The pH value, intrinsic viscosity, tensile strength, orientation degree and degree of crystallinity decreased gradually, and the weight loss of PGLA sutures increased with the degradation time. At 6th week, tensile strength of PGLA sutures nearly reached zero, and weight loss approached to 70% at 8th week. The results of DSC showed that melting point of crystalline region of PGLA sutures substantially remained unchanged and melting heat enthalpy increased gradually during in vitro degradation, and the new ordered regions appeared in the amorphous area. The results of SEM showed that surface coating of PGLA sutures spalled initially, and then the sutures occured transverse rupture. Therefore PGLA suture is suitable to prepare decomposable esophageal stent to expand benign esophageal stenosis or stricture, but stent prepared by PLLA suture is not appropriate for treatment of benign esophageal stenosis because it is decomposed for more than 2 months. © 2013 Springer-Verlag.


Zhu A.,Shandong Institute of Medical Instruments | Wang Q.,Shandong Institute of Medical Instruments | Wang C.,Shandong Institute of Medical Instruments | Liu Y.,Shandong Institute of Medical Instruments | And 2 more authors.
Fuhe Cailiao Xuebao/Acta Materiae Compositae Sinica | Year: 2013

A series of poly(L-lactide-co-glycolide-co-ε-caprolactone) (PLLGC) were synthesized by ring-opening polymerization with L-lactide (L-LA), glycolide (GA) and ε-caprolactone (ε-CL). The degradation behavior of PLLGC was investigated in simulated intestinal fluid at 37°C in vitro within a month. The changes of molecular weight, molecular weight distribution, composition of the polymer, thermal properties, surface morphology and mechanical properties were researched by GPC, 1H-NMR, DSC, SEM and tensile strength. The PCL component appears the most resistant to degradation, and the PGA, the most degradable according to compositional changes. The changes of the molecular weight and mass loss of the terpolymers during degradation tell us that the molecular weight decrease rapidly in the 15 days' degradation and the soluble oligomers release from the bulk sample after 15 days' degradation, and the mass loss was about 15%-40% after 30 days' degradation. The DSC results show that the Tg decreases from 55°C to 34°C, and the melting peak appeared in DSC curves after 30 days' degradation. The changes of the tensile strength during degradation show that the tensile strength decrease slowly in 10days' degradation with good mechanical stability, and decrease from 64-65 MPa to 35-37 MPa after 30 days' degradation.


Wang Q.,Shandong Institute of Medical Instruments | Wang C.,Shandong Institute of Medical Instruments | Du X.,Shandong Institute of Medical Instruments | Liu Y.,Shandong Institute of Medical Instruments | Ma L.,Shandong Institute of Medical Instruments
Journal of Macromolecular Science, Part A: Pure and Applied Chemistry | Year: 2013

A series of biodegradable triblock copolymers PLA-PEG-PLA were synthesized by ring-opening polymerization of D,L-lactide using PEG as initiator. The structures and molecular weights of the triblock copolymers were characterized by1H-NMR and GPC.Their thermal properties were tested by DSC. The thermosensitive gelation behaviors and hydrolytic degradation were investigated. Sol-gel transition was observed with proper LA/EG ratios from 2.23 to 2.57. Besides, the sol-gel transition temperature has a close relation with the concentration and molecular weight of the triblock copolymers. The hydrolytic degradation experiment indicates the copolymers with lower LA/EG ratios degrade faster, and the degradation probably occurred at the PLA block at random. © 2013 Taylor & Francis Group, LLC.


Du X.,Shandong Institute of Medical Instruments | Wang Q.,Shandong Institute of Medical Instruments | Wang C.D.,Shandong Institute of Medical Instruments | Liu Y.,Shandong Institute of Medical Instruments
Advanced Materials Research | Year: 2014

Three biodegradable amphiphilic triblock copolymers: polylactide-poly(ethylene glycol)-polylactide (PLA-PEG-PLA), poly(ε-caprolactone)-poly(ethylene glycol)-poly (ε-caprolactone) (PCL-PEG-PCL) and poly(lactide-glycolide)-poly(ethylene glycol)-poly (lactide-glycolide) (PLGA-PEG-PLGA) were synthesized. Their chemical structures were characterized. In aqueous solution, their self-assembly and degradation were studied by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Spherical micelles were formed in aqueous solution via self-assembly of the amphiphilic triblock copolymers. After degradation, the PLA-PEG-PLA and PCL-PEG-PCL micelles became smaller and the PLGA-PEG-PLGA micelles change to vesicles, which should mainly attribute to their different degradation speed. © (2014) Trans Tech Publications, Switzerland.


Wang Q.,Shandong Institute of Medical Instruments | Wang C.,Shandong Institute of Medical Instruments | Liu Y.,Shandong Institute of Medical Instruments | Ma L.,Shandong Institute of Medical Instruments
Gaofenzi Cailiao Kexue Yu Gongcheng/Polymeric Materials Science and Engineering | Year: 2012

Poly(L-lactide-co-ε-caprolactone) with various L-lactide/ε-caprolactone(LLA/CL) mole ratios was prepared by ring-opening polymerization using stannous octoate as a catalyst. 1H and 13C-NMR measurements indicate that the copolymer compositions are in agreement with mole ratios of LLA/CL feed. The transesterification causes redistribution of comonomer sequences. The coefficient of the second mode of transesterification ([CLC]) increases with CL content increasing. The copolymer composition affects the average sequence length of L-lactidyl (L LL) and caproyl (L C). Both L LL and L C increase with the feed proportion of their respective monomers. L LL and L C are close to L LL R and L C R calculated from a random distribution of units as CL≤50mol%, and distribution of the copolymer is toward a random sequence. Results of DSC and WAXD show that copolymer crystallinity is closely related to the length of their sequence. The copolymer compositions influence significantly their mechanical properties. As the mole content of CL is less than or equal to 35%, the copolymers exhibit the characteristic of yield deformation and high elasticity of thermoplastic elastomer.


Zhu A.,Shandong Institute of Medical Instruments | Wang Q.,Shandong Institute of Medical Instruments | Wang C.,Shandong Institute of Medical Instruments | Liu Y.,Shandong Institute of Medical Instruments | And 2 more authors.
Gaofenzi Cailiao Kexue Yu Gongcheng/Polymeric Materials Science and Engineering | Year: 2013

Poly(L-lactide-co-glycolide-co-ε-caprolactone) (PLLGC) was synthesized by ring-opening polymerization using L-lactide, glycolide and ε-caprolactone. The influences of compression moulding parameters such as preheating temperature, moulding pressure, mould temperature and moulding time on the properties of PLLGC were researched by orthogonal experiment to determine the optimal processing parameters. The influences of the processing parameters on the tensile strength, density, molecular weight and molecular weight distribution of PLLGC after compression moulding were researched by range analysis. The results show that the optimum compression moulding parameters of PLLGC are as follows: preheating temperature of 150°C, moulding pressure of 8 MPa, mold temperature of 100°C, and molding time of 10 min.

Loading Shandong Institute of Medical Instruments collaborators
Loading Shandong Institute of Medical Instruments collaborators